Big news from BackTable Tumor Board 👉 We’ve got 7 brand-new episodes recorded in-studio during our NMIBC Creator Weekend, and they drop starting October 7. This series covers it all — from diagnostics and patient-centered care to sequencing therapies, biomarker data, and

As #NSCLC treatments get more complex, is a collaborative tumor board more essential than ever? We kicked off the 2025 Creator Weekend™ with a panel of top LA experts (surgery, med onc, rad onc, IP) to discuss the critical role of multidisciplinary care. Listen here:

The KEYNOTE-689 trial is a game-changer for head and neck cancer, but how do you actually use it in the clinic? In our new episode, a tumor board of surgeons and oncologists from @unchealth and @TJUHospital breaks down the practical side. Watch the full episode:

November is Lung Cancer Awareness Month and we’re going in-depth. ⬇️ BackTable Tumor Board is bringing you a 6-part in-studio series exploring the evolving landscape of non-small cell lung cancer care. From multidisciplinary tumor board discussions to the latest in systemic,

🎙️ICYMI: The BackTable Tumor Board team recently hosted a NMIBC Creator Weekend in San Diego! Over the course of the weekend, we recorded eight brand-new episodes covering the latest in NMIBC diagnosis, treatment sequencing, biomarkers, and multidisciplinary care. All 8

Season 3 of BackTable Tumor Board is LIVE! Our 8-episode deep dive into the complete management of Non-Muscle Invasive Bladder Cancer. This season is your guide to the latest strategies, from diagnosis to advanced therapeutics. Across the season we cover the entire spectrum of

Playlist Now Live:

Kidney cancer management is evolving. How are experts adapting? In this installment of BackTable Tumor Board, Dr. Brandon Manley, Dr. Raquibul Hannan, and Dr. Rana McKay join guest host Dr. Mark Ball to share their multidisciplinary perspectives on challenging, real-world

📆 ICYMI: September is Prostate Cancer Awareness Month, and we recently brought together Dr. Neeraj Agarwal, and Dr. Tyler Seibert with host Dr. Parth Modi for a multidisciplinary discussion on the evolving landscape of prostate cancer care. They examine: - Emerging data from

How is multidisciplinary collaboration reshaping care for patients with spinal tumors? In this episode of BackTable Tumor Board, host @alexalevey sits with @DrAmsbaugh and @LadorRan for a deep dive into innovations in spinal oncology. They discuss: - Unique patient-centered

How are ongoing clinical trials shaping the future of care for oligometastatic and advanced prostate cancer? In a new collaboration episode with BackTable Urology, host Dr. Parth Modi sits down with Dr. Neeraj Agarwal, MD, FASCO, and Dr. Tyler Seibert for a multidisciplinary

Escalating dose without escalating risk ☢️‼️ Tune into #MSK81 for more #radiationoncology tips in #multidisciplinary #spinaltumor treatment

That’s a wrap on Creator Weekend in San Diego! 🎬 Our team, along with leading experts in urology, came together to record 7 new episodes on NMIBC - designed to spark important conversations and share practical insights with the community. Stay tuned for these episodes and more

True innovation in spinal oncology isn’t a new tool—it’s the collective expertise of every discipline at the table. #SpineOncology #MIS #RadiationOncology #Multidisciplinary #Collaboration #MemorialHermann #MSK81

From OR to outcomes: How minimally invasive, team-based care is reshaping spinal oncology treatment. #SpineOncology #MIS #RadiationOncology #Multidisciplinary #Collaboration #MemorialHermann #MSK81

Are there better intravesical options than BCG? This week, Dr. Lindsey Herrell from @UMichUrology joins @RuchikaTalwarMD to explore therapies for intermediate risk #bladdercancer. #ONC19 @wandering_gu @BenPockros @theusinghal @stensy @angiesmith_uro https://t.co/Q73tNyOw9s

This week on BT ONC: @RuchikaTalwarMD and @KKBree discuss the various treatment options for intermediate-risk #NMIBC. #ONC18 #bladdercancer @MDAndersonNews @UCSDUrology @VUMCUrology @ASCO @UroGenPharma @UroDocAsh @tompowles1 @shilpaonc @BladderCancerUS https://t.co/auNb8NG8hL

🎉 We made the list! Our FREE CME on Combination Therapies for HCC just hit the Top 20 on myCME. Join thousands of peers advancing liver cancer care - and earn credit while you do it! ➡️ Enroll now: https://t.co/AQW9d8ZkQq #CME #MedEd

This week on BT Tumor Board: Episode 17 focuses on #penilecancer diagnosis and treatment, featuring #UroOnc Dr. Charles Peyton, #RadOnc Dr. Juanita Crook, and #MedOnc Dr. Andrea Apolo. #ONC17 @apolo_andrea @UABUrology @GTumorBoard @ASCO https://t.co/3GvoDXmDjV